| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 1999;15:597-601
© 1999 Elsevier Science NL
a Clinique Chirurgicale, Calmette hospital, Rue du Pr J Leclerc 59037 Lille Cedex, France
b Radiologie Ouest, Huriez hospital, Lille University hospital, Rue du Pr J Leclerc 59037 Lille Cedex, France
Received 5 October 1998; received in revised form 6 January 1999; accepted 27 January 1999.
Corresponding author. Tel.: +33-3-2044-4559; fax: +33-3-2044-4890.
Objectives: This study was undertaken: (1) to evaluate the usefulness of unenhanced computed tomography (CT), magnetic resonance imaging (MRI) and CT guided biopsy for the characterization of adrenal masses in patients with operable non-small-cell lung cancer (NSCLC) and (2) to evaluate the situations in which CT guided biopsy is absolutely necessary before potentially curative resection of NSCLC. Methods: Consecutive patients with operable NSCLC underwent unenhanced adrenal CT with density measurements of any adrenal mass over 1 cm in diameter. An adrenal mass was considered as an adenoma when its density was below 10 Hounsfield Units and a metastasis when its density exceeded 10 Hounsfield Units. Then patients underwent MRI, the signal on the T2 weighted images from the enlarged gland was classified adenoma or metastasis in comparison with that from the liver parenchyma. CT guided biopsy was performed after a pheochromocitoma was eliminated. Unenhanced CT attenuation values and signal intensity values on MRI were correlated with histopathologic results. Results: Of the 443 patients, 32 had an adrenal mass consisting of adrenal metastases in 18 cases and adenomas in 14 cases. On CT, 3/14 (21%) of the adenomas were misdiagnosed as metastases (their densities exceeded 10 Hounsfield Units) and 2/18 (11%) of the metastases were misdiagnosed as adenomas (their densities were below 10 Hounsfield Units). On MRI, none of the metastases were misdiagnosed as an adenoma (100% sensitivity) but 7/14 (50%) of the adenomas were misdiagnosed as metastases (signal superior to that of liver). Overall, a diagnostic certainty of metastasis could not be obtained in 25/32 patients (78%). CT guided biopsy with 100% sensitivity and specificity corrected all the inaccurate results of CT and MRI without any morbidity. Conclusion: Despite extensive morphological evaluation with unenhanced CT and conventional MRI, CT guided biopsy is necessary for most patients referred to surgery for an operable NSCLC and an adrenal mass.
Key Words: Non-small-cell lung cancer • Adrenal gland metastasis • Adrenal gland adenoma • Computed tomography scan • Magnetic resonance imaging • Computed tomography guided biopsy
This article has been cited by other articles:
|
|
 |
|
  R. Vikram, H. D. W. Yeung, H. A. Macapinlac, and R. B. Iyer Utility of PET/CT in Differentiating Benign from Malignant Adrenal Nodules in Patients with Cancer Am. J. Roentgenol., November 1, 2008; 191(5): 1545 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 178S - 201S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lucchi, P. Dini, M. C. Ambrogi, P. Berti, G. Materazzi, P. Miccoli, and A. Mussi Metachronous adrenal masses in resected non-small cell lung cancer patients: therapeutic implications of laparoscopic adrenalectomy Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 753 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Nabi and J. M. Zubeldia Clinical Applications of 18F-FDG in Oncology J. Nucl. Med. Technol., March 1, 2002; 30(1): 3 - 9. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
